<abstract xmlns="http://www.w3.org/1999/xhtml"><p>In the 1970s, the most common causes of drug-induced immune hemolytic anemia were methyldopa and penicillin. Since 1990, the most common causes of drug-induced immune hemolytic anemia have been the second- and third-generation cephalosporins, cefotetan and ceftriaxone. Three case histories illustrate the common findings in the serologic investigation of immune hemolytic anemias due to these two drugs. <bold><italic>Immunohematology</italic> 2002;18:27–32</bold>.</p></abstract>

In the 1970s, the most common causes of drug-induced immune hemolytic anemia were methyldopa and penicillin. Since 1990, the most common causes of drug-induced immune hemolytic anemia have been the second- and third-generation cephalosporins, cefotetan and ceftriaxone. Three case histories illustrate the common findings in the serologic investigation of immune hemolytic anemias due to these two drugs. Immunohematology 2002;18:27–32.

Practical aspects of investigating drug-induced immune hemolytic anemia due to cefotetan or ceftriaxone—a case study approach

Immunohematology

In the 1970s, the most common causes of drug-induced immune hemolytic anemia were methyldopa and penicillin. Since 1990, the most common causes of drug-induced...

Practical aspects of investigating drug-induced immune hemolytic anemia due to cefotetan or ceftriaxone—a case study approach

Online veröffentlicht: 14. Okt. 2020

Seitenbereich: 27 - 32

DOI: https://doi.org/10.21307/immunohematology-2019-504

Schlüsselwörter
drug-induced immune hemolytic anemia, cefotetan, ceftriaxone, case studies

© 2002 P.A. Arndt et al., published by Sciendo

Practical aspects of investigating drug-induced immune hemolytic anemia due to cefotetan or ceftriaxone—a case study approach

Online veröffentlicht: 14. Okt. 2020

Seitenbereich: 27 - 32

DOI: https://doi.org/10.21307/immunohematology-2019-504

Schlüsselwörterdrug-induced immune hemolytic anemia, cefotetan, ceftriaxone, case studies

© 2002 P.A. Arndt et al., published by Sciendo

Schlüsselwörter
drug-induced immune hemolytic anemia, cefotetan, ceftriaxone, case studies